Zhaoxing Pan

Dr. Zhaoxing Pan

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
CRCorey Rynders
Corey Rynders
ETElizabeth A Thomas
Elizabeth A Thomas
AZAdnin Zaman
Adnin Zaman
ZPZhaoxing Pan
Zhaoxing Pan
VCVictoria A. Catenacci
Victoria A. Catenacci
EMEdward L. Melanson
Edward L. Melanson
The current obesity epidemic is staggering in terms of its magnitude and public health impact. Current guidelines recommend continuous energy restriction (CER) along with a comprehensive lifestyle intervention as the cornerstone of obesity treatment, yet this approach produces modest weight loss on average. Recently, there has been increased interest in identifying alternative dietary weight loss strategies that involve restricting energy intake to certain periods of the day or prolonging the fasting interval between meals (i.e., intermittent energy restriction, IER). These strategies include intermittent fasting (IMF; >60% energy restriction on 2–3 days per week, or on alternate days) and time-restricted feeding (TRF; limiting the daily period of food intake to 8–10 h or less on most days of the week). Here, we summarize the current evidence for IER regimens as treatments for overweight and obesity. Specifically, we review randomized trials of ≥8 weeks in duration performed in adults with overweight or obesity (BMI ≥ 25 kg/m2) in which an IER paradigm (IMF or TRF) was compared to CER, with the primary outcome being weight loss. Overall, the available evidence suggests that IER paradigms produce equivalent weight loss when compared to CER, with 9 out of 11 studies reviewed showing no differences between groups in weight or body fat loss.

29 August 2022 in Trials
Verified
Journal Article
Open access
PDF file
DODanielle Ostendorf
Danielle Ostendorf
ACAnn E. E Caldwell
Ann E. E Caldwell
AZAdnin Zaman
Adnin Zaman
ZPZhaoxing Pan
Zhaoxing Pan
KBKristen Bing
Kristen Bing
VCVictoria A. Catenacci
Victoria A. Catenacci
Background: The standard of care for treating overweight and obesity is daily caloric restriction (DCR). While this approach produces modest weight loss, adherence to DCR declines over time and weight regain is common. Intermittent fasting (IMF) is an alternative dietary strategy for reducing energy intake (EI) that involves >60% energy restriction on 2–3 days per week, or on alternate days, with habitual intake on fed days. While numerous studies have evaluated IMF as a weight loss strategy, there are several limitations including lack of a standard-of-care DCR control, failure to provide guideline-based behavioral support, and failure to rigorously evaluate dietary and PA adherence using objective measures. To date, only three longer-term (52-week) trials have evaluated IMF as a weight loss strategy. None of these longer-duration studies reported significant differences between IMF and DCR in changes in weight. However, each of these studies has limitations that prohibit drawing generalizable conclusions about the relative long-term efficacy of IMF vs. DCR for obesity treatment. Methods: The Daily Caloric Restriction vs. Intermittent Fasting Trial (DRIFT) is a two-arm, 52-week block randomized (1:1) clinical weight loss trial. The two intervention arms (DCR and IMF) are designed to prescribe an equivalent average weekly energy deficit from baseline weight maintenance energy requirements. Both DCR and IMF will be provided guideline-based behavioral support and a PA prescription. The primary outcome is change in body weight at 52 weeks. Secondary outcomes include changes in body composition (dual-energy x-ray absorptiometry (DXA)), metabolic parameters, total daily energy expenditure (TDEE, doubly labeled water (DLW)), EI (DLW intake-balance method, 7-day diet diaries), and patterns of physical activity (PA, activPAL device). Discussion: Although DCR leads to modest weight loss success in the short-term, there is wide inter-individual variability in weight loss and poor long-term weight loss maintenance. Evidence-based dietary approaches to energy restriction that are effective long-term are needed to provide a range of evidence-based options to individuals seeking weight loss. The DRIFT study will evaluate the long-term effectiveness of IMF vs. DCR on changes in objectively measured weight, EI, and PA, when these approaches are delivered using guideline-based behavioral support and PA prescriptions.

1 August 1998 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
JBJosé E. Barrera
José E. Barrera
HAHong Ai
Hong Ai
ZPZhaoxing Pan
Zhaoxing Pan
AMArlen D. Meyers
Arlen D. Meyers
MVMarileila Varella-Garcia
Marileila Varella-Garcia
HEAD AND NECK cancer is estimated to account for 30300 new cases and 8000 deaths in 1998 in the United States.1 The single most important prognostic factor for head and neck squamous cell carcinoma (HNSCC) is complete surgical removal of the neoplasm, and failure to eradicate the primary tumor is the leading cause of death for patients.2,3 If microscopic cancer is present at a margin of resection, the rate of local recurrence increases substantially and the survival rate decreases.4 The presence of metastatic squamous cell cancer in cervical lymph nodes also increases the risk of local, regional, and distant metastatic spread, correlating with a 50% decrease in survival.3

1 April 2021 in The Journal of Pediatrics
Verified
Journal Article
Closed access
PMPooja Mehta
Pooja Mehta
ZPZhaoxing Pan
Zhaoxing Pan
SSStephanie Skirka
Stephanie Skirka
BKBethany M. Kwan
Bethany M. Kwan
CMCalies Menard-Katcher
Calies Menard-Katcher

21 May 2018 in Obesity Science & Practice
Verified
Journal Article
Open access
PDF file
KSK. J. Speaker
K. J. Speaker
RSRichard Sayer
Richard Sayer
JPJohn Peters
John Peters
HFH. N. Foley
H. N. Foley
ZPZhaoxing Pan
Zhaoxing Pan
JHJames O Hill
James O Hill
Summary: Objective: This 12‐month randomized, non‐inferiority clinical trial sought to determine the impact of consuming soy protein as part of an energy‐restricted, high‐protein diet on weight loss, body composition and cardiometabolic health.Methods: Seventy‐one adults (58 female) with overweight or obesity (body mass index: 32.9 ± 3.6 kg m−2) were randomly assigned to consume three servings of soy (S) or non‐soy (NS) protein foods per day for 12 months. All participants completed a group‐based behavioural weight loss program lasting 4 months (M4), and follow‐up assessments were completed at month 12 (M12).Results: Body weight was reduced in both groups at M4 (S: −7.0% ± 5.2%, NS: −7.1% ± 5.7%) and M12 (S: 3.6% ± 5.1%, NS: −4.8% ± 7.3%). Body weight reductions (mean difference [90% confidence interval]) were not different between S and NS at either time point (M4: −0.16% [−1.4, 3.6], P = 0.90; M12: 1.1% [−1.4, 3.6], P = 0.44). Differences in body fat mass loss were not different between S and NS at M4 (0.29 ± 0.84 kg, P = 0.73) or M12 (0.78 ± 1.5 kg, P = 0.59). Weight loss‐induced improvements in cholesterol, triglycerides and blood pressure did not differ between S and NS.Conclusion: These results indicate that soy‐based protein foods can be effectively incorporated into an energy‐restricted, high‐protein diet for improving body weight, body composition and cardiometabolic health.

1 May 2019 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Open access
JMJacob A. Mark
Jacob A. Mark
BABradley T. Anderson
Bradley T. Anderson
ZPZhaoxing Pan
Zhaoxing Pan
CMCalies Menard‐Katcher
Calies Menard‐Katcher
RKRobert E. Kramer
Robert E. Kramer
Background: Pneumatic balloon and bougie dilation are widely used methods for pediatric esophageal dilation. There are no studies directly comparing the safety of these techniques in pediatric patients. This study compared adverse events (AEs) of balloon and bougie dilation in children at a single institution.Methods: AEs were identified by means of a prospective clinical registry of all procedure related AEs from 2012 to 2015 at a single institution. Identified AEs underwent retrospective review of procedural and clinical details. The category of each AE was recorded and severity was assigned using a 5‐point scoring system. AEs were compared between balloon and bougie dilation for different severities.Results: There were 105 patients who underwent 246 dilation sessions. Balloon dilation was performed more commonly (n = 190, 77%) as compared to Maloney dilators (n = 56, 23%). Patients with balloon dilation were younger (3.0 vs 14.5 years, P = 0.0001) and more likely to have strictures from caustic ingestion (42% vs 2%, P < 0.0001) or surgical anastomoses (34% vs 5% P < 0.0001). Bougie dilation was used more commonly in patients with eosinophilic esophagitis (77% vs 7%, P < 0.0001)). In multivariate analysis, each year of increasing age was associated with a 12% increase in any AEs (P = 0.015), but no difference in clinically significant AEs (grade 2 or higher) was identified between dilation methods.Conclusions: Bougie and balloon dilation did not have significant differences in AE rates, but the patient populations differed between the 2 methods. The dilation method should depend on stricture characteristics and endoscopist expertise with each method.